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Abstract
Binding sites for the CCAAT-enhancer binding protein (C/EBP) family are present in the promoter regions of several
genes that are known to be expressed by mesangial cells (MC) during the pathogenesis of glomerular inflammatory diseases.
The precise regulation of the C/EBP family by agents that are known to activate MC is, however, poorly understood. We
report here the action of interleukin-1 (IL)-1 and, for the first time, lipopolysaccharide (LPS), platelet-derived growth
factor (PDGF), IL-6, interferon-Q (IFN-Q) and tumour necrosis factor-K (TNF-K) on the C/EBP expression profile and
functional DNA binding activity in primary rat MC. Both cell-type- and stimulus-specific regulation of C/EBP mRNA
expression and DNA binding activity were identified, with C/EBPK being induced by LPS, C/EBPL by LPS, IL-1, TNF-K
and C/EBPN by LPS, IL-1, IFN-Q, TNF-K and PDGF. Such differential regulation, particularly that of C/EBPL, may be
responsible for the mediator-specific differences in the expression of C/EBP-regulated genes in MC. Additionally, the
involvement of potential post-transcriptional mechanisms in the regulation of C/EBPN were identified. These studies provide
novel insights into the stimulus-specific regulation of gene expression during renal diseases. ß 2000 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Activated mesangial cells (MC) play a crucial role
in the pathogenesis of glomerular in£ammatory dis-
eases, including glomerulonephritis [1]. Cytokines
have emerged as the most important modulators of
MC function during renal diseases [1^3] and lipo-
polysaccharide (LPS) activates MC during infection
both directly, by binding to speci¢c receptors on the
cell surface, and indirectly, through the production
of secondary e¡ectors [4]. The action of such medi-
ators includes the regulation of both cell prolifera-
tion and the expression of speci¢c genes. Unfortu-
nately, the precise mechanisms by which these
mediators regulate gene expression remains currently
unclear and further studies are necessary in order to
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obtain a detailed understanding of the molecular ba-
sis of renal in£ammatory diseases.
Binding sites for the CCAAT-enhancer binding
protein (C/EBP) family of transcription factors
have been identi¢ed in the promoter regions of sev-
eral genes that are known to be activated in nephritic
glomeruli, including cytokines [e.g. interleukin (IL)-1,
IL-6], chemokines [e.g. IL-8, monocyte chemoat-
tractant protein-1 (MCP-1)], inducible nitric oxide
synthase (iNOS) and group II phospholipase A2
(sPLA2) [5^7]. An understanding of the mechanisms
by which the expression of these genes is regulated
by agents that are known to activate MC clearly
requires a thorough analysis of the regulation of
the C/EBP family members in these cells. Such infor-
mation may also shed light on the mechanisms that
are responsible for the mediator-speci¢c di¡erential
activation of these genes, with LPS, IL-1 and tumour
necrosis factor-K (TNF-K) able to activate the ma-
jority of them and only a subset being induced by
platelet-derived growth factor (PDGF), interferon-Q
(IFN-Q) and IL-6 [1^4,8^11]. For example, the ex-
pression of IL-6 is induced by LPS and TNF-K but
not IFN-Q [8,9]. Additionally, IL-1 and TNF-K in-
duce iNOS and sPLA2 expression whilst PDGF an-
tagonises this e¡ect [10,11] and the expression of IL-
8 is activated by LPS, IL-1 and TNF-K but not IFN-
Q [8,12].
The C/EBP family consists of six members
(C/EBPK^j) that are capable of forming heterodimers
in all intrafamilial combinations [5^7]. Additionally,
in the case of C/EBPK and C/EBPL, polypeptides of
di¡erent sizes and trans-activating capabilities are
known to be produced from the same mRNA, by
alternative use of in-frame initiation codons because
of the existence of a leaky ribosome scanning mech-
anism [13,14]. Thus, the range of C/EBP proteins
that may be present in any given tissue/cell may be
wider than the number of C/EBP-encoding genes; for
example, at least 14 combinations are possible from
the various polypeptides produced from the C/EBPK,
-L and -N mRNA. At present, insight into the regu-
lation of C/EBP in MC by LPS and cytokines is
restricted to analysis of representative members by
IL-1 and IL-4 [15,16]. In order to further understand
the potential mechanisms that are involved in the
stimulus-speci¢c activation of gene expression in
MC, the present study examined the action of a
range of mediators (LPS, IL-1, IL-6, IFN-Q, PDGF
and TNF-K) on the C/EBP mRNA expression and
the functional DNA binding activity in primary cul-
tures of rat MC. To our knowledge this is the ¢rst
study in which the action of such a wide range of
mediators on the expression of the C/EBP family in
MC has been investigated.
2. Materials and methods
2.1. Materials
Lipopolysaccharide from Escherichia coli (serotype
055:B5) was from Sigma (Poole, Dorset, UK) with
the recombinant cytokines (human IL-1K, IL-6,
PDGF-BB; murine IFN-Q, TNF-K) being from Gen-
zyme (Cambridge, MA, USA), Peprotech (London,
UK) or the National Institute for Biological Stand-
ards (Hertfordshire, UK). All the cell culture re-
agents were purchased from Gibco BRL (Paisley,
UK). Antisera used for some electrophoretic mobi-
lity shift assay (EMSA) were purchased from Santa
Cruz (Santa Cruz, CA, USA).
2.2. Cell culture
MC were obtained from outgrowth cultures of
collagenase-treated glomeruli isolated from adult
Wistar rats using standard procedures [17]. The cells
were cultured in RPMI 1640, which was supple-
mented with 20% (v/v) heat-inactivated (30 min,
56‡C) foetal calf serum (HI-FCS), 100 Wg/ml strepto-
mycin, 100 U/ml penicillin, 4 mM L-glutamine,
20 mM HEPES, 5 Wg/ml insulin, 5 Wg/ml transferrin
and 5 ng/ml sodium selenite, at 37‡C in a humidi¢ed
atmosphere of 5% (v/v) CO2 in air, with all ex-
periments being performed with cells in the third
to seventh passage. The homogeneity of MC was
veri¢ed by their stellate fusiform morphology, their
positive staining for actin, desmin and vimentin and
the absence of staining for factor VIII and cytoker-
atin.
Before exposure to the mediators, cells were pre-
incubated overnight in medium containing 0.5% (v/v)
HI-FCS. The medium was then removed and re-
placed with fresh medium containing 0.5% (v/v)
HI-FCS and the appropriate concentration of the
BBADIS 61932 19-5-00
R.L. Granger et al. / Biochimica et Biophysica Acta 1501 (2000) 171^179172
mediator (1 Wg/ml LPS, 10 ng/ml PDGF, 1000 U/ml
IL-1, IL-6, IFN-Q or TNF-K) [18,19].
2.3. Reverse transcription polymerase chain reaction
(RT-PCR)
Total cellular RNA was prepared using either Tri-
Reagent LS (Molecular Research Center, Cincinnati,
OH, USA), RNeasy total isolation kit (Qiagen,
Crawley, UK) or SNAP kit (Invitrogen, CA, USA).
Each isolated RNA sample [1 Wg; as determined us-
ing the Genequant Spectrophotometer (Pharmacia,
St. Albans, UK)] was treated with RNase-free
DNase-I (Promega, Southampton, UK) and then
used as template to generate random-primed cDNA
according to the manufacturer’s protocol (Clontech,
Palo Alto, CA, USA). PCR reactions were carried
out essentially as described previously [20] except
that the annealing temperature was 60‡C. The se-
quences of the primers were 5P-AAGGCCAAGAA-
GTCGGTGGA-3P and 5P-CAGTTCACGGCTCA-
GCTGTT-3P for C/EBPK, 5P-GCGCGAGCGCAA-
CAACATC-3P and 5P-TGCTTGAACAAGTTCCG-
CAG-3P for C/EBPL, 5P-GCGCGAGCGCAACAA-
CATC-3P and 5P-CCAGGTCCCGGGTGAGCT-3P
for C/EBPN and 5P-TGGAGAAGAGCTATGAGC-
TGCCTG-3P and 5P-GTGCCACCAGACAGCACT-
GTGTTG-3P for L-actin [20].
The PCR products were size-fractionated on 2%
(w/v) agarose gels, transferred onto Nylon mem-
branes and hybridised to the appropriate radiola-
belled cDNA inserts as described previously [20].
2.4. EMSA
The oligonucleotides for EMSA analysis were la-
belled using ‘¢ll-in’ reactions carried out in the pres-
ence of [K-32P]dCTP and Klenow DNA polymerase.
The sequences of the oligonucleotides used were 5P-
TGCAGATTGCGCAAT-3P and 5P-TGCAATTGC-
GCAATC-3P for the C/EBP binding site and 5P-GA-
TCCTTCGTGACTCAGCGGGATCCTTCGTGA-
G-3P and 5P-CCGCTGACTCACGAAGGATCCC-
GCTGAGTCACG-3P for the activator protein-1
(AP-1) binding site [20,21].
Nuclear extracts were prepared essentially as de-
scribed by Ramji et al. [22], with all bu¡ers contain-
ing the protease inhibitors phenylmethylsulfonyl £u-
oride (PMSF) (0.5 mM), pepstatin A (1 Wg/ml),
aprotinin (10 Wg/ml), leupeptin (10 Wg/ml) and I-S
soybean trypsin inhibitor (10 Wg/ml). For EMSA,
4Wg of nuclear extracts were incubated in a 20 Wl
total reaction volume containing 34 mM potassium
chloride, 5 mM magnesium chloride, 0.1 mM DTT
and 3 Wg poly (dI-dC). After 10 min on ice, 32P-
labelled probes (40 000 cpm) were added and the in-
cubation continued for 20 min at room temperature.
Following addition of 5 Wl of a 20% (w/v) Ficoll so-
lution to each sample, the free probe and DNA^pro-
tein complexes were resolved on 6% (w/v) polyacryl-
amide gels. For antibody supershift assays, samples
of the nuclear extracts and 2 Wl of the antisera were
incubated for 30 min on ice prior to the addition of
the radiolabelled probe [20,22].
3. Results
3.1. The action of LPS and cytokines on C/EBP
mRNA expression
The levels of mRNA coding for the C/EBP mem-
bers were determined by semi-quantitative RT-PCR
using total cellular RNA from MC exposed either to
LPS or individual cytokines for varying periods of
time from 0 to 24 h. The analysis was restricted to
the C/EBPK, -L and -N genes for cells treated with
LPS, TNF-K or IL-6 and the C/EBPL and -N genes in
the case of cells incubated with PDGF, IL-1 and
IFN-Q. The concentration of the mediators used
was based on previous studies on the regulation of
gene expression in MC and other cell types, including
those from our laboratory [18,19]. The conditions for
PCR used were within the exponential phase of am-
pli¢cation and, therefore, provided a direct correla-
tion between the amount of ampli¢cation products
and RNA template abundance in the samples. Be-
cause the expression of the L-actin gene is known
to be una¡ected in MC by the mediators used, RT-
PCR using primers speci¢c for the L-actin gene were
also carried out in parallel in order to provide a
control for variations in input of cDNA. The PCR
products generated were subjected to Southern blot
analysis using probes speci¢c for individual C/EBP
members or the L-actin gene. After densitometric
scanning of the autoradiographs, the signals from
BBADIS 61932 19-5-00
R.L. Granger et al. / Biochimica et Biophysica Acta 1501 (2000) 171^179 173
the C/EBP genes were normalised to that from L-
actin, assigning the ratio in unstimulated cells as
1 in each case. In all cases, no products were
produced when reverse transcriptase was omitted
from the RT-PCR reactions (data not shown) and
a product of the expected size was obtained when
primers designed against two di¡erent exons in the
L-actin gene were used (Fig. 1), thereby indicating
that the PCR ampli¢cation was speci¢c and that
the products were not derived from any contamina-
tion of the samples with genomic DNA. In addition,
the speci¢city of PCR ampli¢cation was con¢rmed
by sequence analysis of representative products
(data not shown).
The trends in C/EBP expression described here are
based on reproducible changes observed in independ-
ent experiments with Fig. 1 showing the outcome of
one such experimental series. The steady state levels
of C/EBPK mRNA increased immediately following
exposure of MC to LPS to reach peak levels at 6 h
and declined gradually thereafter. In contrast, treat-
ment of the cells with TNF-K or IL-6 had no e¡ect.
The expression of C/EBPL mRNA was not a¡ected
signi¢cantly by exposure of the cells to IL-6, PDGF
or IFN-Q but induced by LPS, TNF-K and IL-1. On
the other hand, the steady state levels of C/EBPN
mRNA were una¡ected by exposure of the cells to
IL-6, but induced by LPS, TNF-K, PDGF, IL-1 and
IFN-Q. The induction of C/EBPL and C/EBPN
mRNA expression by IL-1 is consistent with a pre-
vious report that used the alternative technique of
Northern blot analysis [15]. Representative RT-
PCR were also carried out using RNA from un-
treated cells at 6, 12 and 24 h. These controls showed
no changes in the constitutive expression levels of all
three C/EBP genes (data not shown), thereby con-
¢rming that the changes in C/EBP gene expression
observed were speci¢cally due to the action of the
mediators.
3.2. The e¡ect of LPS and cytokines on the C/EBP
DNA binding activity
EMSA were carried out in order to evaluate the
potential functional consequences of C/EBP mRNA
expression on DNA binding activity. The analysis
was restricted to cells exposed of two mediators
that activate C/EBP mRNA expression (LPS, TNF-
K) and one that has no e¡ect (IL-6). Additionally, in
contrast to IL-6, both LPS and TNF-K activate the
majority of genes in MC, the promoters of which
contain potential binding sites for the C/EBP family
[1^4,8,9,12,23]. The C/EBP binding site oligonucleo-
tide chosen for the analysis has been used previously
to investigate global changes in C/EBP DNA binding
activity in several di¡erent physiological and patho-
physiological conditions [20,22,24]. Overall, at least
four DNA^protein complexes were observed using
extracts from cells exposed to the mediators (CL1^
CL4, CT1^CT4 and CI1^CI4 in Fig. 2). None of
these complexes were present when only the radio-
labelled probe was used (i.e. in the absence of nuclear
extracts) (see Fig. 3).
Exposure of MC to LPS or cytokines resulted in
both the appearance of new DNA^protein complexes
and changes in the activity of proteins in speci¢c
DNA^protein complexes that were already present
in extracts from unstimulated cells. Additionally,
stimulus-speci¢c changes were identi¢ed. For cells
stimulated with LPS, complexes CL-1 and CL-4
were undetectable in extracts from the control (i.e.
0 h) and 30 min time points while complexes CL-2
Fig. 1. RT-PCR analysis of the mRNA levels for C/EBP family members in MC following exposure to LPS or cytokines. The cells
were treated with LPS (A), TNF-K (B), IL-6 (C), IFN-Q (D), PDGF (E) and IL-1 (F) for the time periods indicated. cDNA was pre-
pared from total cellular RNA and used in PCR reactions in which primers against individual C/EBP family members or L-actin were
present. The ampli¢cation products were size-fractionated by electrophoresis on 2% (w/v) agarose gels and, with the exception of the
L-actin control in PDGF- and IL-1-treated cells (E and F), transferred onto Nylon membrane and probed with radiolabelled cDNA
inserts for C/EBPK, -L, -N or L-actin as indicated. The signals at each point were determined by densitometric scanning with the C/
EBP family member: L-actin ratio in unstimulated cells being assigned as 1 and the ratio for the remaining cell samples being repre-
sented relative to this control value (indicated by numbers in the ¢gure). The data shown is representative of two to four independent
experimental series, all of which produced a similar pattern of changes in C/EBP gene expression to those described in the text. The
decrease in signal intensity seen for some early time points in this ¢gure (i.e. ratio 6 1.0) was not observed reproducibly.
C
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and CL-3 were present at low levels. The activity of
all four complexes began to increase following incu-
bation of the cells with LPS for 1 h, reached peak
levels at 6 h and declined dramatically at 12 h. For
cells exposed to TNF-K, complex CT1 was absent in
unstimulated cells, appeared after 1 h and its activity
then increased continuously up to 12 h. Complexes
CT2^CT4 were all present when extracts from un-
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treated cells were used. Their activity remained at
approximately similar levels between 0 and 1 h and
increased thereafter to reach peak levels at 12 h. On
the other hand, in contrast to cells treated with LPS
or TNF-K, a decrease in the binding activity of all
the complexes was observed reproducibly when MC
were exposed to IL-6, reaching the lowest levels at
3 h. The activity of complexes CI1^CI3 showed a
marginal increase at subsequent time points.
The speci¢city of the various DNA^protein com-
plexes shown in Fig. 2 was con¢rmed by competition
EMSA. Thus, the various complexes could be com-
peted out in a concentration-dependent manner using
a 50-, 100- or 500-fold molar excess of unlabelled
C/EBP binding site oligonucleotide but not with the
same molar excess of an unrelated AP-1 binding site
oligonucleotide (data not shown).
3.3. Identi¢cation of the C/EBP family members
involved in DNA^protein interactions
Antibody interference EMSA experiments were
carried out in order to identify the nature of the
C/EBP proteins that were involved in DNA^protein
interactions. The analysis was restricted to the use of
nuclear extracts from MC exposed to LPS or TNF-K
for 6 h and IL-6 for 3 h. These time points were
chosen because they coincide with an increase in
C/EBP DNA binding activity for MC exposed to
LPS or TNF-K and peak induction of a majority
of genes that are regulated by the mediators and a
decrease in the case of IL-6 (see Fig. 2). The extracts
and antisera were incubated together prior to the
addition of the C/EBP binding site oligonucleotide.
In the case of all three mediators, a reduction of
speci¢c DNA^protein complexes and the appearance
of antibody^DNA^protein supershifted complex(es)
were obtained with antisera against C/EBPK and
C/EBPL, but not the pre-immune serum (Fig. 3),
thereby indicating a major contribution of these
two isoforms in DNA binding. Because the activity
of a number of di¡erent DNA^protein complexes
could be reduced by both these two antisera, it was
likely that homo- or hetero-dimers of the di¡erent
polypeptides that are known to be produced from
the C/EBPK and C/EBPL mRNA by alternate use
of translation initiation codons [13,14] participated
in DNA^protein interactions. In contrast, an anti-
body^DNA^protein supershifted complex with the
C/EBPN antisera was only seen with extracts from
TNF-K-treated cells that was derived from complex
CT3, thus suggesting that this isoform made only a
minor contribution to DNA binding and was, there-
fore, likely to be subject to post-transcriptional con-
trol in MC. Additionally, the potential involvement
of members other than C/EBPK, -L or -N was sug-
gested by the lack of any major e¡ect of the antisera
used on complexes such as CI1 (Fig. 3).
Fig. 2. Time course of C/EBP DNA binding activity in LPS or cytokine stimulated cells. MC were either untreated (0 h) or incubated
with LPS (A), TNF-K (B) or IL-6 (C), for the periods of time indicated. Nuclear extracts prepared from the cells were then used for
EMSA with a C/EBP binding site oligonucleotide. The various DNA^protein complexes (CL1^CL4, CT1^CT4 and CI1^CI4) are
shown by labelled arrows; the free probe has migrated o¡ the gel. The variation in signal intensity for time 0 re£ects di¡erences in
autoradiographic exposures. The data shown is representative of two independent experimental series.
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4. Discussion
Regulation of the C/EBP family of transcription
factors in mesangial cells is of potentially critical
importance in the pathogenesis of glomerular in£am-
matory diseases. Although functional redundancy be-
tween C/EBPK, -L, and -N in the regulation of gene
expression has been reported [5^8,25], stimulus-spe-
ci¢c qualitative and quantitative di¡erences have
been identi¢ed in the expression of genes, the pro-
moter regions of which contain binding sites for the
C/EBP family [1^4,8^12,23]. In general, LPS, IL-1
and TNF-K activate the majority of such genes
with only a subset being induced by the other medi-
ators. It is, therefore, interesting to note that the
expression of C/EBPL mRNA was induced by LPS,
IL-1 and TNF-K but not PDGF, IFN-Q and IL-6.
Because C/EBPK mRNA is only activated by LPS
and antibody interference experiments indicate only
a minor involvement of C/EBPN in DNA^protein in-
teractions, it is likely that homodimers of C/EBPL,
or heterodimers with another member (particularly
C/EBPK), makes a major contribution to stimulus-
speci¢c di¡erential activation of C/EBP-regulated
genes. In support of this proposition, it has been
shown that IL-1 and IL-4 cooperatively stimulate
IL-6 gene expression in MC through synergistic acti-
vation of C/EBPL [16]. Other di¡erences such as the
kinetics and magnitude of changes in C/EBP mRNA
expression and DNA binding activity may account
for subtle mediator-speci¢c quantitative di¡erences
in the expression of such genes.
The responses identi¢ed here show several di¡er-
ences to those in other cell types, thereby indicating
the existence of potential tissue/cell-speci¢c mecha-
nisms in the regulation of C/EBP gene expression.
For example, TNF-K has no e¡ect on the C/EBPL
mRNA levels in the hepatoma RALA255-10G
cell line [26], LPS and IL-6 reduce the levels of
C/EBPK mRNA in hepatocytes and macrophages
[25,27] and IL-6 induces the expression of C/EBPN
mRNA in hepatocytes [22,27]. Such di¡erences may
in turn be responsible for cell-speci¢c di¡erences in
the activation of down-stream genes.
In contrast to LPS and TNF-K, a time-dependent
reduction of total C/EBP DNA binding activity by
IL-6 was observed. The precise signi¢cance of this
unique action of IL-6 is currently unclear although
it should be noted that, in contrast to the other me-
diators used, both pro-in£ammatory and anti-in£am-
matory e¡ects of IL-6 on MC have been reported [1^
3]. Additionally, IL-6 has been shown to modulate
antibody-mediated glomerular injury in vivo and re-
duce the glomerular concentration of mRNA for
Fig. 3. Identi¢cation of the C/EBP members involved in DNA^protein interactions. EMSA were carried out using nuclear extracts
from MC treated for 6 h with either LPS or TNF-K or for 3 h with IL-6, in the presence of antiserum against C/EBPK (K), C/EBPL
(L), C/EBPN (N) or pre-immune serum (PI). Lanes P, C and S represent the pattern obtained with the free probe, extracts from un-
treated cells and those stimulated with the appropriate mediator, respectively. Labelled arrows indicate the position of the various
DNA^protein complexes and vertical line shows the antibody^protein^DNA ‘supershifted’ complex(es) (SS). The variation in signal in-
tensity for lane C re£ects di¡erences in autoradiographic exposures.
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both IL-1L and TNF-K [1^3]. Such a reduction could
potentially be mediated through the observed de-
crease in C/EBP DNA binding activity.
A comparison of the changes in C/EBP mRNA
expression and functional DNA binding activity sug-
gests that both transcriptional and post-transcrip-
tional mechanisms are likely to be involved in the
regulation of C/EBPs in MC. For example, the acti-
vation of C/EBP mRNA (K and L by LPS and L and
N by TNF-K) and corresponding time-dependent in-
crease in DNA binding activity suggests a major con-
tribution of changes in mRNA metabolism (tran-
scription or mRNA stability) for the observed
changes. However, an important role of translational
or post-translational mechanisms is suggested by the
following observations: (i) the DNA binding activity
of C/EBPs is reduced by IL-6 despite little changes in
mRNA expression (Figs. 1 and 2), (ii) C/EBPN rep-
resents only a minor DNA binding component de-
spite its mRNA levels being induced between 1 and
6 h following stimulation with LPS and TNF-K
(Figs. 1 and 3) and (iii) antibody supershift experi-
ments with extracts from the chosen time point in-
dicate a major contribution of heterodimers between
the di¡erent C/EBP isoforms, particularly the various
C/EBPK and C/EBPL polypeptides that are known to
be produced by alternative use of translation initia-
tion codons, in DNA^protein interaction (Fig. 3). As
the di¡erent C/EBP polypeptides are known to di¡er
in their trans-activation potential [5^7], such changes
in the composition of heterodimers may have a dra-
matic e¡ect on gene expression. C/EBPs are also
known to be regulated by extracellular mediators
by phosphorylation via several di¡erent kinases, in-
cluding protein kinase A and MAP kinase [5^7,28]. It
is therefore possible that such changes in phosphor-
ylation status may also play a major role in the po-
tential post-translational modulation of C/EBP ac-
tion in MC that is suggested by the current studies,
particularly the changes in the DNA binding activity.
The importance of cytokines in the pathogenesis of
renal disease is well established and the mediators
that we have studied here have been shown to be
elevated in the nephritogenic glomerulus. More spe-
ci¢cally, these factors have been implicated to play a
pivotal role in glomerulonephritis, by either increas-
ing cell proliferation, recruitment of leukocytes,
modelling of matrix and production of secondary
mediators [1^4]. Although many such events have
been catalogued and some of the signalling pathways
have been examined [1^4], there is still a relative
paucity of information on how LPS and cytokines
exert their e¡ects at the level of gene transcription
in renal cells during glomerulonephritis. The data
presented here identify potential mechanisms for
stimulus-speci¢c di¡erential regulation of C/EBP-
modulated genes in a key cell type from the glomer-
ulus and is likely to play an important role in the
progression of renal diseases. Although the data pre-
sented has been obtained from experiments on cul-
tured cells in vitro, it is also likely to be applicable in
vivo in light of what is already known regarding
cytokine expression and action in both human pa-
tients and animal models of glomerulonephritis [1^4].
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